Aims

To support the free and open dissemination of research findings and information on alcoholism and alcohol-related problems. To encourage open access to peer-reviewed articles free for all to view.

For full versions of posted research articles readers are encouraged to email requests for "electronic reprints" (text file, PDF files, FAX copies) to the corresponding or lead author, who is highlighted in the posting.

___________________________________________

Monday, February 18, 2008

Stock News - Alcoholism drug market: shift in disease perception required for long-term growth

 Feb 18, 2008 (Datamonitor via COMTEX) -- ALKS | news | PowerRating | PR Charts -- Estimated to be worth just $86 million in 2006, the alcohol dependence pharmaceutical market is set to grow to $304 million by 2016, driven by the launch of two pipeline opioid antagonists and the continued uptake of Alkermes and Cephalon's opioid antagonist Vivitrol. However, for substantial long-term success in drug treatment for alcohol dependence, a shift in disease perception is required.
. . . . . .

Read Full Article
____________________________________________________________________________________________________
at